{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T05:09:29Z","timestamp":1733202569121,"version":"3.30.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,2]]},"DOI":"10.7759\/cureus.74958","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T11:21:41Z","timestamp":1733138501000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Remission of Refractory Rheumatoid Pleural Effusion and Arthritis Using Sarilumab: A Case Report"],"prefix":"10.7759","author":[{"given":"Atsuhiko","family":"Sunaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-007-0322-9","article-title":"Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate?","volume":"27","author":"Avnon LS","year":"2007","unstructured":"Avnon LS, Abu-Shakra M, Flusser D, Heimer D, Sion-Vardy N. Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate?. Rheumatol Int. 2007, 27:919-25. 10.1007\/s00296-007-0322-9","journal-title":"Rheumatol Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000244","article-title":"Pleural effusion, pneumothorax, and lung entrapment in rheumatoid arthritis","volume":"21","author":"Komarla A","year":"2015","unstructured":"Komarla A, Yu GH, Shahane A. Pleural effusion, pneumothorax, and lung entrapment in rheumatoid arthritis. J Clin Rheumatol. 2015, 21:211-5. 10.1097\/RHU.0000000000000244","journal-title":"J Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.39093","article-title":"Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: Results of a phase III study","volume":"67","author":"Genovese MC","year":"2015","unstructured":"Genovese MC, Fleischmann R, Kivitz AJ, et al.. Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: Results of a phase III study. Arthritis Rheumatol. 2015, 67:1424-37. 10.1002\/art.39093","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.39944","article-title":"Sarilumab and nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis and inadequate response or intolerance to tumor necrosis factor inhibitors","volume":"69","author":"Fleischmann R","year":"2017","unstructured":"Fleischmann R, van Adelsberg J, Lin Y, et al.. Sarilumab and nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis and inadequate response or intolerance to tumor necrosis factor inhibitors. Arthritis Rheumatol. 2017, 69:277-90. 10.1002\/art.39944","journal-title":"Arthritis Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.5.698","article-title":"Local immune responses in certain extra-articular manifestations of rheumatoid arthritis","volume":"51","author":"Halla JT","year":"1992","unstructured":"Halla JT, Schrohenloher RE, Koopman WJ. Local immune responses in certain extra-articular manifestations of rheumatoid arthritis. Ann Rheum Dis. 1992, 51:698-701. 10.1136\/ard.51.5.698","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.96.09081652","article-title":"Pleural fluid interferon-gamma and tumour necrosis factor-alpha in tuberculous and rheumatoid pleurisy","volume":"9","author":"S\u00f6derblom T","year":"1996","unstructured":"S\u00f6derblom T, Nyberg P, Teppo AM, Klockars M, Riska H, Pettersson T. Pleural fluid interferon-gamma and tumour necrosis factor-alpha in tuberculous and rheumatoid pleurisy. Eur Respir J. 1996, 9:1652-5. 10.1183\/09031936.96.09081652","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00001.x","article-title":"Congestive heart failure in old age","volume":"243","author":"Jolobe OM","year":"1998","unstructured":"Jolobe OM. Congestive heart failure in old age. J Intern Med. 1998, 243:327. 10.1046\/j.1365-2796.1998.00001.x","journal-title":"J Intern Med"},{"key":"ref8","article-title":"Rheumatoid pleural effusion: lack of response to intrapleural corticosteroid","volume":"13","author":"Russell ML","year":"1986","unstructured":"Russell ML, Gladman DD, Mintz S. Rheumatoid pleural effusion: lack of response to intrapleural corticosteroid. J Rheumatol. 1986, 13:412-5.","journal-title":"J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-224034","article-title":"Treatment of refractory rheumatoid pleural effusion with abatacept","volume":"2018","author":"Fujita S","year":"2018","unstructured":"Fujita S, Mukai T, Akagi T, Morita Y. Treatment of refractory rheumatoid pleural effusion with abatacept. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-224034","journal-title":"BMJ Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.874745","article-title":"A case of bilateral rheumatoid pleuritis successfully treated with tocilizumab","volume":"24","author":"Ohtsuka K","year":"2014","unstructured":"Ohtsuka K, Takeuchi K, Matsushita M, Aramaki T. A case of bilateral rheumatoid pleuritis successfully treated with tocilizumab. Mod Rheumatol. 2014, 24:1001-4. 10.3109\/14397595.2013.874745","journal-title":"Mod Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1360-3","article-title":"Etanercept related pseudo-empyema in rheumatoid arthritis","volume":"29","author":"Rimar D","year":"2010","unstructured":"Rimar D, Rozenbaum M, Slobodin G, Boulman N, Rosner I. Etanercept related pseudo-empyema in rheumatoid arthritis. Clin Rheumatol. 2010, 29:547-9. 10.1007\/s10067-009-1360-3","journal-title":"Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1795","article-title":"Differential binding of sarilumab and tocilizumab to IL-6R\u03b1 and effects of receptor occupancy on clinical parameters","volume":"61","author":"Xu C","year":"2021","unstructured":"Xu C, Rafique A, Potocky T, et al.. Differential binding of sarilumab and tocilizumab to IL-6R\u03b1 and effects of receptor occupancy on clinical parameters. J Clin Pharmacol. 2021, 61:714-24. 10.1002\/jcph.1795","journal-title":"J Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317469-successful-remission-of-refractory-rheumatoid-pleural-effusion-and-arthritis-using-sarilumab-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T11:21:43Z","timestamp":1733138503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317469-successful-remission-of-refractory-rheumatoid-pleural-effusion-and-arthritis-using-sarilumab-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.74958","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,2]]}}}